Key facts
- This page summarizes John Glenn's Form 3 filing for IRADIMED CORP (IRMD).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Jun 2022, 19:16.
John Glenn - 20 Jun 2022 Form 3 Insider Report for IRADIMED CORP (IRMD)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- IRMD
- Reported as of
- 20 Jun 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 22 Jun 2022, 19:16:34 UTC
- Prior SEC filing
- 28 Mar 2022
- Next SEC filing
- 09 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Glenn
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Glenn filed Form 3 for IRADIMED CORP (IRMD) on 22 Jun 2022.
Change
- Previous filing in this sequence was filed on 28 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.